Profile data is unavailable for this security.
About the company
Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
- Revenue in PLN (TTM)299.00k
- Net income in PLN27.01m
- Incorporated2008
- Employees15.00
- LocationPharmena SAul. Wolczanska 178LODZ 90-530PolandPOL
- Phone+48 422913370
- Fax+48 422913371
- Websitehttps://www.pharmena.eu/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harper Hygienics SA | 282.38m | 8.89m | 37.37m | 584.00 | 4.20 | 0.5523 | 2.13 | 0.1324 | 1.40 | 1.40 | 44.35 | 10.63 | 0.9385 | 4.69 | 3.08 | -- | 2.95 | -0.7789 | 5.53 | -1.45 | 23.89 | 22.20 | 3.15 | -0.8215 | 0.7555 | 2.67 | 0.6118 | -- | 5.54 | -- | 104.34 | -- | -- | -- |
| Brand Architekts Group PLC | 90.72m | -28.05m | 38.45m | 50.00 | -- | 0.313 | -- | 0.4238 | -0.2006 | -0.2006 | 0.6489 | 0.8786 | 0.5075 | 1.72 | 3.51 | 362,640.00 | -15.59 | -7.14 | -17.91 | -8.68 | 40.33 | 33.99 | -30.71 | -18.25 | 3.03 | -- | 0.00 | -- | 40.49 | -0.9671 | -52.43 | -- | -58.68 | -- |
| Clemondo Group AB (publ) | 102.79m | 3.67m | 46.85m | 51.00 | 12.76 | 1.14 | 5.00 | 0.4558 | 0.0719 | 0.0719 | 2.01 | 0.8044 | 1.39 | 3.75 | 8.05 | 5,468,588.00 | 4.98 | 6.57 | 7.56 | 11.12 | 36.08 | 38.86 | 3.57 | 4.38 | 0.6163 | 5.09 | 0.2103 | 0.00 | -6.79 | 0.7884 | 164.56 | -- | -24.33 | -- |
| Miraculum SA | -100.00bn | -100.00bn | 48.14m | 54.00 | -- | 2.23 | -- | -- | -- | -- | -- | 0.5212 | -- | -- | -- | -- | -- | -5.49 | -- | -7.50 | -- | 32.61 | -- | -8.88 | 0.2163 | -- | 0.5011 | -- | 8.66 | 16.18 | 33.44 | -- | -11.53 | -- |
| Hortico SA | 155.52m | 10.63m | 65.23m | -- | 6.01 | 1.05 | 5.11 | 0.4195 | 0.8406 | 0.8406 | 12.13 | 4.80 | 1.43 | 2.25 | 4.97 | -- | 9.79 | 10.40 | 17.83 | 22.01 | 30.20 | 27.82 | 6.84 | 6.79 | 0.8259 | 55.88 | 0.0631 | -- | -1.63 | 10.08 | -37.71 | 41.49 | 11.70 | -- |
| Candles Scandinavia AB | 62.94m | -2.01m | 69.09m | 46.00 | -- | 2.23 | -- | 1.10 | -0.696 | -0.696 | 20.32 | 10.97 | 1.11 | -- | 7.35 | -- | -3.52 | -- | -4.27 | -- | -- | -- | -3.17 | -- | 3.69 | -1.03 | 0.00 | -- | 33.10 | -- | 107.25 | -- | -- | -- |
| Roblon A/S | 196.82m | -5.32m | 71.88m | 267.00 | -- | 0.7415 | 7.33 | 0.3652 | -5.16 | -5.20 | 190.81 | 111.27 | 1.02 | 2.95 | 4.61 | -- | -2.77 | -1.03 | -3.87 | -1.33 | 13.54 | 13.90 | -2.70 | -1.06 | 1.22 | -4.15 | 0.2871 | -- | -8.08 | 9.55 | -97.52 | -- | -3.23 | -- |
| Pharmena SA | 299.00k | 27.01m | 72.40m | 15.00 | 2.68 | 3.21 | 2.65 | 242.13 | 2.43 | 2.60 | 0.0269 | 2.02 | 0.0163 | 0.1198 | 0.1959 | 19,933.33 | 147.19 | 1.11 | 291.02 | 5.11 | -0.3345 | 55.39 | 9,035.79 | 1.87 | 12.92 | 2,350.57 | 0.0082 | -- | 0.00 | -53.00 | 628.36 | -- | -6.78 | -- |
| Creightons plc | 282.42m | 5.92m | 85.59m | 472.00 | 17.93 | 0.6601 | 6.08 | 0.3031 | 0.0139 | 0.0139 | 0.6836 | 0.3787 | 1.20 | 2.79 | 4.18 | 119,589.00 | 2.51 | 8.73 | 3.64 | 12.69 | 42.50 | 41.37 | 2.10 | 5.13 | 1.12 | 4.05 | 0.2178 | -- | -4.24 | 10.97 | -83.47 | -16.04 | -0.721 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2023 | 153.00k | 1.37% |
| ESALIENS TFI SAas of 30 Jun 2020 | 31.50k | 0.28% |
